IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rick Costantino who wrote (1180)	7/29/1997 8:43:00 PM
From: Roudy	of 1762

Rick and all, Thanks for the feedback. I guess I'm a little mythed on playing this stock for over a year and then find out I could buy it at a much lower risk factor and reasonable price compared to the years price movement. Perhaps one should be buying these biotechs on the heals of FDA Panel reviews. I think the only way we see IDPH go lower is if CE9.1 is terminated as Bennett has eluded to. I believe it would be short term though. I did hear that the problem with CE9.1 was in commercial manufacturing and hopefully the second generation CE9.1 hurdles this obstacle. Something else to look forward to, is the approval of C2B8 in Europe. This could also be a nice boost to the stock. I may start whining more often, I see the stock did close up nicely, today. Don

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next